Yu Han

发表

Rotating magnetic field induced oscillation of magnetic particles for in vivo mechanical destruction of malignant glioma.

Y. Cheng, R. Cowburn, C. Horbinski, 2016, Journal of controlled release : official journal of the Controlled Release Society.

Short hairpin RNA-mediated fibronectin knockdown delays tumor growth in a mouse glioma model.

S. Sengupta, S. Nandi, D. Wainwright, 2010, Neoplasia.

Nanoparticle-programmed self-destructive neural stem cells for glioblastoma targeting and therapy.

Atique U. Ahmed, Chin-Tu Chen, Y. Cheng, 2013, Small.

Intranasal delivery of mesenchymal stem cells significantly extends survival of irradiated mice with experimental brain tumors.

Atique U. Ahmed, I. Balyasnikova, M. Lesniak, 2014, Molecular therapy : the journal of the American Society of Gene Therapy.

A safety and efficacy study of local delivery of interleukin-12 transgene by PPC polymer in a model of experimental glioma

A. Sonabend, K. Anwer, H. Brem, 2008, Anti-cancer drugs.

Survivin-driven and fiber-modified oncolytic adenovirus exhibits potent antitumor activity in established intracranial glioma.

A. Rivera, D. Curiel, I. Ulasov, 2007, Human gene therapy.

A comparative study of neural and mesenchymal stem cell-based carriers for oncolytic adenovirus in a model of malignant glioma.

Atique U. Ahmed, B. Thaci, I. Ulasov, 2011, Molecular pharmaceutics.

Neural stem cell-based cell carriers enhance therapeutic efficacy of an oncolytic adenovirus in an orthotopic mouse model of human glioblastoma.

Atique U. Ahmed, I. Balyasnikova, B. Thaci, 2011, Molecular therapy : the journal of the American Society of Gene Therapy.

Pharmacokinetic study of neural stem cell-based cell carrier for oncolytic virotherapy: Targeted delivery of the therapeutic payload in an orthotopic brain tumor model

Atique U. Ahmed, B. Thaci, I. Ulasov, 2012, Cancer Gene Therapy.

A preclinical evaluation of neural stem cell-based cell carrier for targeted antiglioma oncolytic virotherapy.

Atique U. Ahmed, Y. Cheng, C. Kim, 2013, Journal of the National Cancer Institute.

Mesenchymal Stem Cells Modified with a Single-Chain Antibody against EGFRvIII Successfully Inhibit the Growth of Human Xenograft Malignant Glioma

S. Sengupta, I. Balyasnikova, M. Lesniak, 2010, PloS one.

Controlled Payload Release by Magnetic Field Triggered Neural Stem Cell Destruction for Malignant Glioma Treatment

Y. Cheng, R. Cowburn, R. Mansell, 2016, PloS one.

Neural Stem Cells Secreting Anti‐HER2 Antibody Improve Survival in a Preclinical Model of HER2 Overexpressing Breast Cancer Brain Metastases

Atique U. Ahmed, Dihua Yu, Deepak Kanojia, 2015, Stem cells.

Mesenchymal stem cell carriers enhance antitumor efficacy of oncolytic adenoviruses in an immunocompetent mouse model

R. Alemany, A. Alfranca, Deepak Kanojia, 2017, Oncotarget.

Elongated Nanoparticle Aggregates in Cancer Cells for Mechanical Destruction with Low Frequency Rotating Magnetic Field

G. Plaza, B. Liu, Yu Cheng, 2017, Theranostics.

HIF-1α Is a Metabolic Switch between Glycolytic-Driven Migration and Oxidative Phosphorylation-Driven Immunosuppression of Tregs in Glioblastoma

Atique U. Ahmed, N. Chandel, P. Zhang, 2019, Cell reports.

Inhibition of MMP14 potentiates the therapeutic effect of temozolomide and radiation in gliomas

C. Kim, B. Thaci, I. Ulasov, 2013, Cancer medicine.

Novel recombinant adenoviral vector that targets the interleukin-13 receptor alpha2 chain permits effective gene transfer to malignant glioma.

I. Ulasov, M. Lesniak, Yu Han, 2007, Human gene therapy.

Enhanced transduction of malignant glioma with a double targeted Ad5/3-RGD fiber-modified adenovirus

P. Fisher, P. Dent, D. Curiel, 2006, Molecular Cancer Therapeutics.

Characterization and Immunotherapeutic Implications for a Novel Antibody Targeting IL-13 Receptor alpha2

Gina Lee, I. Balyasnikova, B. Thaci, 2012 .

Bone marrow mesenchymal stem cells loaded with an oncolytic adenovirus suppress the anti-adenoviral immune response in the cotton rat model.

Atique U. Ahmed, S. Sengupta, I. Balyasnikova, 2010, Molecular therapy : the journal of the American Society of Gene Therapy.

Oncolytic adenoviral vectors which employ the survivin promoter induce glioma oncolysis via a process of beclin-dependent autophagy.

T. He, I. Ulasov, M. Lesniak, 2009, International journal of oncology.

Heme oxygenase-1 protects regulatory T cells from hypoxia-induced cellular stress in an experimental mouse brain tumor model

Atique U. Ahmed, I. Balyasnikova, D. Wainwright, 2014, Journal of Neuroimmunology.

Progression of intracranial glioma disrupts thymic homeostasis and induces T-cell apoptosis in vivo

M. Lesniak, Yu Han, A. Andaloussi, 2008, Cancer Immunology, Immunotherapy.

Low-dose radiation enhances survivin-mediated virotherapy against malignant glioma stem cells.

L. Molinero, S. Nandi, I. Ulasov, 2008, Cancer research.

CD46 represents a target for adenoviral gene therapy of malignant glioma.

I. Ulasov, M. Lesniak, Yu Han, 2006, Human gene therapy.

A Comparative Study of Replication-Incompetent and -Competent Adenoviral Therapy-Mediated Immune Response in a Murine Glioma Model

Jacob S. Young, Deepak Kanojia, I. Balyasnikova, 2017, Molecular therapy oncolytics.

A chimeric adenovirus with an Ad 3 fiber knob modification augments glioma virotherapy

S. Nandi, I. Ulasov, M. Lesniak, 2009, The journal of gene medicine.

Short Hairpin RNA-Mediated Fibronectin Knockdown Delays Tumor Growth in a Mouse

S. Sengupta, S. Nandi, D. Wainwright, 2010 .

Cross-priming of T cells to intracranial tumor antigens elicits an immune response that fails in the effector phase but can be augmented with local immunotherapy

I. Ulasov, M. Lesniak, T. Gajewski, 2006, Journal of Neuroimmunology.

Blood-brain barrier permeable gold nanoparticles: an efficient delivery platform for enhanced malignant glioma therapy and imaging.

Yu Cheng, Yu Han, Xiaobing Fan, 2014, Small.

IDO Expression in Brain Tumors Increases the Recruitment of Regulatory T Cells and Negatively Impacts Survival

Atique U. Ahmed, Kyung-Sub Moon, I. Balyasnikova, 2012, Clinical Cancer Research.

Dendritic Cell–Based Vaccines that Utilize Myeloid Rather than Plasmacytoid Cells Offer a Superior Survival Advantage in Malignant Glioma

Atique U. Ahmed, I. Balyasnikova, D. Wainwright, 2015, The Journal of Immunology.

A Genetically Modified Adenoviral Vector with a Phage Display-Derived Peptide Incorporated into Fiber Fibritin Chimera Prolongs Survival in Experimental Glioma.

Atique U. Ahmed, Jacob S. Young, D. Curiel, 2015, Human gene therapy.

Fiber‐knob modifications enhance adenoviral tropism and gene transfer in malignant glioma

I. Ulasov, M. Lesniak, Yu Han, 2007, The journal of gene medicine.

Multiplexed RNAi therapy against brain tumor-initiating cells via lipopolymeric nanoparticle infusion delays glioblastoma progression

Atique U. Ahmed, Daniel G. Anderson, Hao F. Zhang, 2017, Proceedings of the National Academy of Sciences.

Fibrin-binding, peptide amphiphile micelles for targeting glioblastoma☆

Yu Cheng, Yu Han, Matthew V. Tirrell, 2013, Biomaterials.

Myeloid-Derived Suppressive Cells Promote B cell–Mediated Immunosuppression via Transfer of PD-L1 in Glioblastoma

L. Platanias, C. Horbinski, I. Balyasnikova, 2019, Cancer Immunology Research.

CCL2 Produced by the Glioma Microenvironment Is Essential for the Recruitment of Regulatory T Cells and Myeloid-Derived Suppressor Cells.

Atique U. Ahmed, C. Horbinski, Deepak Kanojia, 2016, Cancer research.

Thymus-derived rather than tumor-induced regulatory T cells predominate in brain tumors.

S. Sengupta, D. Wainwright, M. Lesniak, 2011, Neuro-oncology.

B-cells Drive Response to PD-1 Blockade in Glioblastoma Upon Neutralization of TGFβ-mediated Immunosuppression

Mark W. Youngblood, P. Zhang, Junfei Zhao, 2023, Research square.

Therapeutic effect of neural stem cells expressing TRAIL and bortezomib in mice with glioma xenografts.

I. Balyasnikova, M. Lesniak, Feifei Liu, 2011, Cancer letters.

MSCs Successfully Deliver Oncolytic Virotherapy to Diffuse Intrinsic Pontine Glioma

C. James, D. Curiel, C. Horbinski, 2020, bioRxiv.

Intratumoral oncolytic adenoviral treatment modulates the glioma microenvironment and facilitates systemic tumor-antigen-specific T cell therapy

M. Lesniak, Yu Han, Lingjiao Zhang, 2015, Oncoimmunology.

Mesenchymal Stem Cells Successfully Deliver Oncolytic Virotherapy to Diffuse Intrinsic Pontine Glioma

C. James, D. Curiel, C. Horbinski, 2020, Clinical Cancer Research.

Activation of 4-1BBL+ B cells with CD40 agonism and IFNγ elicits potent immunity against glioblastoma

R. Stupp, C. Horbinski, A. Sonabend, 2020, The Journal of experimental medicine.

FABP7 is a key metabolic regulator in HER2+ breast cancer brain metastasis

Atique U. Ahmed, Deepak Kanojia, Weidong Zhou, 2019, Oncogene.

Durable Therapeutic Efficacy Utilizing Combinatorial Blockade against IDO, CTLA-4, and PD-L1 in Mice with Brain Tumors

Y. Cheng, C. Kim, I. Balyasnikova, 2014, Clinical Cancer Research.

Characterization and Immunotherapeutic Implications for a Novel Antibody Targeting Interleukin (IL)-13 Receptor α2*

Gina Lee, I. Balyasnikova, B. Thaci, 2012, The Journal of Biological Chemistry.

Oncolytic adenoviral therapy for glioblastoma multiforme.

A. Sonabend, I. Ulasov, M. Lesniak, 2006, Neurosurgical focus.

EXPERIMENTAL THERAPEUTICS AND PHARMACOLOGY

Tina N. Davis, Forrest M Kievit, Atique U. Ahmed, 2013 .

Anti-GITR therapy promotes immunity against malignant glioma in a murine model

M. Muroski, M. Lesniak, Yu Han, 2016, Cancer Immunology, Immunotherapy.

Local Application of Autologous Platelet-Rich Fibrin Patch (PRF-P) Suppresses Regulatory T Cell Recruitment in a Murine Glioma Model

P. Zhang, Deepak Kanojia, M. Lesniak, 2018, Molecular Neurobiology.

The Presence of IL-17A and T Helper 17 Cells in Experimental Mouse Brain Tumors and Human Glioma

S. Sengupta, I. Ulasov, D. Wainwright, 2010, PloS one.

A Light‐Triggered Mesenchymal Stem Cell Delivery System for Photoacoustic Imaging and Chemo‐Photothermal Therapy of Triple Negative Breast Cancer

Zuoren Yu, Chang Xu, Qishuai Feng, 2018, Advanced science.

The expression of BST2 in human and experimental mouse brain tumors.

I. Balyasnikova, D. Wainwright, M. Lesniak, 2011, Experimental and molecular pathology.

Anti-angiogenic therapy increases intratumoral adenovirus distribution by inducing collagen degradation

Atique U. Ahmed, B. Thaci, I. Ulasov, 2012, Gene Therapy.

Stimulation of TLR9 with CpG ODN enhances apoptosis of glioma and prolongs the survival of mice with experimental brain tumors

A. Sonabend, M. Lesniak, Yu Han, 2006, Glia.

Prolongation of survival following depletion of CD4+CD25+ regulatory T cells in mice with experimental brain tumors.

M. Lesniak, Yu Han, A. El Andaloussi, 2006, Journal of neurosurgery.

Therapeutic targeting of tumor-associated myeloid cells synergizes with radiation therapy for glioblastoma

Deepak Kanojia, I. Balyasnikova, P. Zhang, 2019, Proceedings of the National Academy of Sciences.

The Timing of Neural Stem Cell‐Based Virotherapy Is Critical for Optimal Therapeutic Efficacy When Applied With Radiation and Chemotherapy for the Treatment of Glioblastoma

Atique U. Ahmed, C. Kim, I. Balyasnikova, 2013, Stem cells translational medicine.

Targeting adenovirus to CD80 and CD86 receptors increases gene transfer efficiency to malignant glioma cells.

A. Rivera, D. Curiel, I. Ulasov, 2007, Journal of neurosurgery.

Adoptive Transfer of IL13Rα2-Specific Chimeric Antigen Receptor T Cells Creates a Pro-inflammatory Environment in Glioblastoma.

I. Balyasnikova, M. Lesniak, S. Gottschalk, 2018, Molecular therapy : the journal of the American Society of Gene Therapy.

GCN2 is essential for CD8+ T cell survival and function in murine models of malignant glioma

Deepak Kanojia, M. Lesniak, Jawad Fares, 2019, Cancer Immunology, Immunotherapy.

Programmable ROS‐Mediated Cancer Therapy via Magneto‐Inductions

G. Plaza, Chang Xu, Qishuai Feng, 2020, Advanced science.

Remote Control of Mechanical Forces via Mitochondrial-Targeted Magnetic Nanospinners for Efficient Cancer Treatment.

G. Plaza, Chang Xu, Yu Cheng, 2019, Small.

Polyamines drive myeloid cell survival by buffering intracellular pH to promote immunosuppression in glioblastoma

Y. Reshetnyak, N. Chandel, C. Horbinski, 2021, Science Advances.

Offer a Superior Survival Advantage in Myeloid Rather than Plasmacytoid Cells Based Vaccines that Utilize - Dendritic Cell

Atique U. Ahmed, I. Balyasnikova, M. Lesniak, 2015 .

Repolarization of myeloid derived suppressor cells via magnetic nanoparticles to promote radiotherapy for glioma treatment.

Yu Cheng, P. Zhang, M. Muroski, 2019, Nanomedicine : nanotechnology, biology, and medicine.

The Dynamic Interactions between Nanoparticles and Macrophages Impact Their Fate in Brain Tumors.

Min Wang, C. Wei, Qishuai Feng, 2021, Small.

STING agonist-loaded, CD47/PD-L1-targeting nanoparticles potentiate antitumor immunity and radiotherapy for glioblastoma

P. Zhang, Junfei Zhao, A. Sonabend, 2023, Nature Communications.

Local Application of Autologous Platelet-Rich Fibrin Patch (PRF-P) Suppresses Regulatory T Cell Recruitment in a Murine Glioma Model

Deepak Kanojia, M. Lesniak, A. Cordero, 2018, Molecular Neurobiology.

Cell-Penetrating Peptide-Modified Gold Nanoparticles for the Delivery of Doxorubicin to Brain Metastatic Breast Cancer.

Yu Cheng, Yu Han, Brenda Auffinger, 2016, Molecular pharmaceutics.

Intranasal Oncolytic Virotherapy with CXCR4-Enhanced Stem Cells Extends Survival in Mouse Model of Glioma

Atique U. Ahmed, Deepak Kanojia, I. Balyasnikova, 2016, Stem cell reports.

Photo-Reactive Oxygen Species Boosting Strategy by Employing Mitochondrial Targeting Zinc-Doped Magnetic Nanoparticles to Enhance Anti-Cancer Therapy

Yu Cheng, Congyu Wu, M. Lesniak, 2019, Nano LIFE.

Conversion of differentiated cancer cells into cancer stem-like cells in a glioblastoma model after primary chemotherapy

Atique U. Ahmed, Gina Lee, M. Lesniak, 2014, Cell Death and Differentiation.

Neural stem cells target intracranial glioma to deliver an oncolytic adenovirus in vivo

Jeffrey Roth, A. Sonabend, S. Nandi, 2009, Gene Therapy.

Fatty Acid Uptake in T Cell Subsets Using a Quantum Dot Fatty Acid Conjugate

M. Muroski, M. Lesniak, Yu Han, 2017, Scientific Reports.

Depletion of myeloid-derived suppressor cells during interleukin-12 immunogene therapy does not confer a survival advantage in experimental malignant glioma

Atique U. Ahmed, Kyung-Sub Moon, L. Zhang, 2014, Cancer Gene Therapy.

Intranasal delivery of mesenchymal stem cells significantly extends survival of irradiated mice with experimental brain tumors.

Atique U. Ahmed, I. Balyasnikova, M. Lesniak, 2014, Molecular therapy : the journal of the American Society of Gene Therapy.

Combination of adenoviral virotherapy and temozolomide chemotherapy eradicates malignant glioma through autophagic and apoptotic cell death in vivo

A. Sonabend, S. Nandi, I. Ulasov, 2009, British Journal of Cancer.